You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neovascular age-related macular degeneration

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration Trial (RRG001)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Nov 15, 2023

Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept 40 MG/ML
  • Faricimab 120 MG/ML
  • Graz, Styria, Austria
    Department of Ophthalmolgy, Medical University Graz
Jul 3, 2023

Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Phoenix, Arizona
    Retinal Research Institute, LLC
Jun 4, 2023

Neovascular Age-related Macular Degeneration Trial (PMC-403)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Jul 11, 2023

Neovascular Age-related Macular Degeneration Trial (AXT107 Low Dose, AXT107 Mid Dose, AXT107 High Dose)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • AXT107 Low Dose
  • +2 more
  • (no location specified)
May 5, 2023

Single Injection of Faricimab for nAMD With Persisting Fluid

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Glostrup, Denmark
    Miklos Schneider
Nov 3, 2023

Neovascular Age-related Macular Degeneration (nAMD) Trial in Abilene (OCU-10-C-110 for Injection)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • OCU-10-C-110 for Injection
  • Abilene, Texas
    Retina Research Institute of Texas
Jun 6, 2023

Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)

Recruiting
  • Age-Related Macular Degeneration
  • VOY-101
  • Sydney, New South Wales, Australia
  • +3 more
Oct 17, 2023

Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • AR-14034 SR implant lower dose
  • +3 more
  • (no location specified)
Mar 3, 2023

Neovascular Age-related Macular Degeneration Trial in Shanghai (LX102-C01 Injection)

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • LX102-C01 Injection
  • Shanghai, China
    Shanghai General Hospital, Shanghai Jiao Tong University School
Apr 14, 2023

Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept Ophthalmic
  • IBI302
  • Suzhou, Jiangsu, China
    Innovent Biologics (Suzhou) Co,Ltd.
Jul 25, 2023

Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)

Not yet recruiting
  • Diabetic Macular Edema (DME)
  • Neovascular Age-Related Macular Degeneration (nAMD)
  • aflibercept 8 mg PFS
  • (no location specified)
Aug 3, 2023

Neovascular Age-related Macular Degeneration Trial in Beijing (IBI333)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • IBI333
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Nov 28, 2022

Neovascular Age-related Macular Degeneration Trial in Katy, Norfolk (SKG0106)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • SKG0106
  • Katy, Texas
  • +1 more
Aug 15, 2023

Age-Related Macular Degeneration Trial in Malvern, Saint Albans (BBC1501)

Not yet recruiting
  • Age-Related Macular Degeneration
  • Malvern, Victoria, Australia
  • +1 more
Apr 5, 2023

Neovascular Age-related Macular Degeneration Trial in Seongnam-si (Probiotic Combination Cap/Tab, intravitreal Anti-VEGF

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Probiotic Combination Cap/Tab
  • intravitreal Anti-VEGF injection
  • Seongnam-si, Korea, Republic of
    Seoul National University Bundang Hospital
Nov 1, 2022

Russian Registry of Patients With nAMD

Terminated
  • Neovascular Age-Related Macular Degeneration
  • nAMD
  • (no location specified)
Jan 16, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),

Suspended
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Intravitreal injection of IBI302(dose 1)
  • +3 more
  • Beijing, Beijing, China
    Peking University People's Hospital
Jul 17, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Mesa, Phoenix (Faricimab PFS Configuration)

Completed
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Faricimab PFS Configuration
  • Mesa, Arizona
  • +2 more
Jan 2, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Austin, Texas
    Retina Consultants of Austin
Jan 16, 2023

Neovascular Age Related Macular Degeneration, nAMD Trial in Wenzhou City (PDS with ranibizumab (100 mg/mL), Ranibizumab (10

Not yet recruiting
  • Neovascular Age Related Macular Degeneration
  • nAMD
  • PDS with ranibizumab (100 mg/mL)
  • Ranibizumab (10 mg/mL)
  • Wenzhou City, China
    Eye Hospital, Wenzhou Medical University
Feb 2, 2023

Early Real-world Evidence of Brolucizumab in Neovascular

Completed
  • Neurovascular Age-related Macular Degeneration
    • Bangalore, India
    • +3 more
    Apr 26, 2023

    Neovascular Age-related Macular Degeneration Trial in United States (OLX10212 is a cell penetrating asymmetric small

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • OLX10212 is a cell penetrating asymmetric small interference RNA (cp-asiRNA)
    • Santa Maria, California
    • +4 more
    Jan 10, 2023

    Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in Tehran (Aflibercept (CinnaGen Co, Iran),

    Completed
    • Age-Related Macular Degeneration
    • Neovascular Age-related Macular Degeneration
    • Aflibercept (CinnaGen Co, Iran)
    • Aflibercept (Regeneron, USA)
    • Tehran, Iran, Islamic Republic of
      Farabi Hospital
    Oct 16, 2022

    Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)

    Recruiting
    • Neovascular Age-related Macular Degeneration (NVAMD)
    • Diabetic Macular Edema (DME)
    • Phoenix, Arizona
    • +4 more
    Jun 14, 2023